https://www.selleckchem.com/pr....oducts/kb-0742-dihyd
Overall RR of 12-month mortality for "No" was 3.76 (95% CI 2.75-5.48); this association remained significant in all provider types. Among statistically significant predictors of 12-month mortality (including recurrent disease and 2 prior lines of chemotherapy), the surprise question had the highest RR. CONCLUSIONS The surprise question is a simple, one question tool that effectively identifies GO patients increased risk of 12-month mortality. The surprise question could be used to identify patients for early referral
Like
Comment
Share
